主要文件

查看所有文档

A79809

5-氨基水杨酸

Name: 5-氨基水杨酸
Brand: ALDRICH

95%

别名:

5-AS, 5-氨基-2-羟基苯甲酸, 氨水杨酸

登录查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:

H₂NC₆H₃-2-(OH)CO₂H

化学文摘社编号:

89-57-6

分子量:

153.14

UNSPSC Code:

12352106

NACRES:

NA.22

PubChem Substance ID:

24891301

EC Number:

201-919-1

Beilstein/REAXYS Number:

2090421

MDL number:

MFCD00007877

技术服务

需要帮助？我们经验丰富的科学家团队随时乐意为您服务。

让我们为您提供帮助

属性

Quality Level

200

assay

95%

form

powder with small lumps

reaction suitability

reaction type: solution phase peptide synthesis

mp

275-280 °C (dec.) (lit.)

application(s)

detection
peptide synthesis

SMILES string

Nc1ccc(O)c(c1)C(O)=O

InChI

1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)

InChI key

KBOPZPXVLCULAV-UHFFFAOYSA-N

Gene Information

human ... ALOX5(240), PPARG(5468), PTGS1(5742), PTGS2(5743)

说明

Application

5-氨基水杨酸是适用于ELISA分析的过氧化物酶底物。这一底物产生可溶性的棕色终产物，可在450nm处通过分光光度法读取。使用3 N NaOH可终止反应并在550 nm处读取结果。

Still not finding the right product?

Explore all of our products under 5-氨基水杨酸

pictograms

GHS07

signalword

Warning

hcodes

H315,H317,H319,H335

pcodes

P261 - P264 - P271 - P280 - P302 + P352 - P305 + P351 + P338

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2 - Skin Sens. 1 - STOT SE 3

target_organs

Respiratory system

存储类别

13 - Non Combustible Solids

wgk

WGK 2

flash_point_f

No data available

flash_point_c

No data available

ppe

dust mask type N95 (US), Eyeshields, Gloves

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本？

如果您需要特殊版本，可通过批号或批次号查找具体证书。

搜索COA

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Phylogenetic analysis of dysbiosis in ulcerative colitis during remission.

Mirjana Rajilić-Stojanović et al.

Inflammatory bowel diseases, 19(3), 481-488 (2013-02-07)

Presence of intestinal microbes is a prerequisite for the development of ulcerative colitis (UC), although deviation of the normal intestinal microbiota composition, dysbiosis, is presumably implicated in the etiology of UC. The fecal microbiota of 30 UC samples obtained from

Modifiable factors associated with nonadherence to maintenance medication for inflammatory bowel disease.

Christian P Selinger et al.

Inflammatory bowel diseases, 19(10), 2199-2206 (2013-08-01)

Poor adherence frequently impaired the efficacy of therapy to maintain remission from inflammatory bowel diseases (IBD). There is a lack of practical and effective interventions to improve adherence. This study aimed to identify modifiable risk factors, which may yield targets

Randomised clinical trial: mesalazine (Salofalk granules) for uncomplicated diverticular disease of the colon--a placebo-controlled study.

W Kruis et al.

Alimentary pharmacology & therapeutics, 37(7), 680-690 (2013-02-19)

Robust evidence regarding medical intervention for symptomatic uncomplicated colonic diverticular disease (DD) is sparse. To investigate mesalazine (Salofalk granules) in this setting. In a double-blind, placebo-controlled, multicentre, 6-week trial, patients were randomised to mesalazine 1000 mg three times daily or placebo.

查看所有相关文献

全球贸易项目编号

货号	GTIN
A79809-100G	04061833390870
A79809-5G	04061833390887